Deutsch English Français

Contact

EP1937304

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1937304

EP1937304 - ZWITTERIONIZATION OF CAPSULAR SACCHARIDES [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 27.06.2014 Database last updated on 11.09.2024
Most recent event Tooltip	27.06.2014	Application deemed to be withdrawn	published on 30.07.2014 [2014/31]
Applicant(s)	For all designated states Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina 1 53100 Siena (SI) / IT
	[2008/27]
Inventor(s)	01 / TELFORD, John Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1 I-53100 Siena / IT
	02 / BERTI, Francesco Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1 I-53100 Siena / IT
	03 / WACK, Andreas Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1 I-53100 Siena / IT
	[2008/27]
Representative(s)	Marshall, Cameron John, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2009/51]	Marshall, Cameron John, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Former [2008/27]	Marshall, Cameron John, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	06831540.7	24.08.2006
	[2008/27]
	WO2006IB02833
Priority number, date	GB20050017353	24.08.2005 Original published format: GB 0517353
	GB20060007738	19.04.2006 Original published format: GB 0607738
	[2008/27]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2007023386
	Date:	01.03.2007
	Language:	EN
	[2007/09]
	Type:	A2 Application without search report
	No.:	EP1937304
	Date:	02.07.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 01.03.2007 takes the place of the publication of the European patent application.
	[2008/27]
Search report(s)	International search report - published on:	EP	05.07.2007
Classification	IPC:	A61K39/09, C08B37/00	[2008/27]
	CPC:	A61K39/092 (EP,US); A61K39/095 (EP,US); A61P31/04 (EP); C08B37/006 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/27]
Title	German:	ZWITTERIONISATION KAPSELFÖRMIGER SACCHARIDE	[2008/27]
	English:	ZWITTERIONIZATION OF CAPSULAR SACCHARIDES	[2008/27]
	French:	ZWITTERIONISATION DE SACCHARIDES CAPSULAIRES	[2008/27]
Entry into regional phase	20.03.2008	National basic fee paid
	20.03.2008	Designation fee(s) paid
	20.03.2008	Examination fee paid
Examination procedure	20.03.2008	Examination requested [2008/27]
	24.11.2009	Despatch of a communication from the examining division (Time limit: M06)
	04.06.2010	Reply to a communication from the examining division
	18.11.2011	Despatch of a communication from the examining division (Time limit: M06)
	29.05.2012	Reply to a communication from the examining division
	01.03.2014	Application deemed to be withdrawn, date of legal effect [2014/31]
	27.03.2014	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/31]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.11.2009
Fees paid	Renewal fee
	20.03.2008	Renewal fee patent year 03
	12.08.2009	Renewal fee patent year 04
	17.08.2010	Renewal fee patent year 05
	11.08.2011	Renewal fee patent year 06
	10.08.2012	Renewal fee patent year 07
	Penalty fee
	Additional fee for renewal fee
	31.08.2013	08 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO9932653 (NORTH AMERICAN VACCINE INC [US], et al) [X] 1,3-15,18,26 * page 16, line 25 - page 18, line 14 *;
		[X]WO03080678 (CHIRON SRL [IT], et al) [X] 1,8,9,14,26 * Scheme 2 * * figure 8 *;
		[X]WO9640795 (NORTH AMERICAN VACCINE INC [US]) [X] 1,8,9,14,26 * page 13 *;
		[XD]US6027733 (WANG YING [US], et al) [XD] 1,8,9,14,22,26 * column 5, lines 35-46; claim 3 *;
		[X] - ZOU W ET AL, "Oligosaccharide fragments of the type III group B streptococcal polysaccharide derived from S. pneumoniae type 14 capsular polysaccharide by a chemoenzymatic method", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, (199807), vol. 309, no. 3, ISSN 0008-6215, pages 297 - 301, XP004145715 [X] 1,3-15,18,26 * figure 1 * DOI: http://dx.doi.org/10.1016/S0008-6215(98)00134-7
		[X] - BASHAM L E ET AL, "A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B Streptococcus type-specific antibodies in humans", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (199604), vol. 14, no. 5, ISSN 0264-410X, pages 439 - 445, XP004057301 [X] 1,3-9,11-14,26 * page 441 * DOI: http://dx.doi.org/10.1016/0264-410X(95)00146-R
		[X] - BARTOLONI A ET AL, "Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (1995), vol. 13, no. 5, ISSN 0264-410X, pages 463 - 470, XP004057721 [X] 1,3-9,11-14,25,26 * page 464 - page 465; figures 1,2 * DOI: http://dx.doi.org/10.1016/0264-410X(94)00007-A
		[X] - SHEN X ET AL, "Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20001122), vol. 19, no. 7-8, ISSN 0264-410X, pages 850 - 861, XP004225405 [X] 1,3-9,11-14,25,26 * page 852 * DOI: http://dx.doi.org/10.1016/S0264-410X(00)00226-7
		[AD] - TZIANABOS A O ET AL, "T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (20000310), vol. 275, no. 10, ISSN 0021-9258, pages 6733 - 6740, XP002206685 [AD] 1-26 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.275.10.6733
		[A] - TZIANABOS A ET AL, "Biological chemistry of immunomodulation by zwitterionic polysaccharides", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, (20031114), vol. 338, no. 23, ISSN 0008-6215, pages 2531 - 2538, XP004479525 [A] 1-26 * the whole document * DOI: http://dx.doi.org/10.1016/j.carres.2003.06.005
	Examination	WO2006082530
		US2003170267

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p